Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.
Supernatants from the coculture of peripheral blood lymphocytes and the NK-susceptible cell line K562 were highly growth inhibitory for a variety of tumor cell lines. No correlation was observed between the susceptibility of the target cell lines to growth inhibition and to lysis by NK cells. Rather, the spectrum of cytostatic activity and the characteristics of the soluble factor were similar to those of leukoregulin, a recently described lymphokine. The supernatants of tumor-lymphocyte cultures contained only low levels of IFN-alpha and IFN-gamma, and antibodies to interferons did not affect the observed growth inhibition. The pattern of target cell susceptibility to growth inhibition by this factor was also quite distinct from that seen with purified recombinant LT or TNF. Furthermore, monoclonal antibodies to these cytokines also had no effect on the cytostasis, arguing against a requirement for, or synergistic interaction with, low levels of these cytokines. Some of the targets susceptible to the factor were only growth inhibited but not lysed, thereby distinguishing it from NKCF. Furthermore, the cytostasis was not inhibited by mannose-6-PO4 or rabbit antibodies to granule cytolysin, both of which have been reported to block NKCF. Therefore, the results show that a cytostatic factor is released in tumor-lymphocyte incubation that is quite distinct from interferons, LT, and TNF but has characteristics that resemble those of leukoregulin.
T J
TJ
Sayers
J H
JH
Ransom
A C
AC
Denn
R B
RB
Herberman
J R
JR
Ortaldo
D000328:Adult; D000818:Animals; D002460:Cell Line; D002474:Cell-Free System; D003602:Cytotoxicity, Immunologic; D006023:Glycoproteins / Q000502:physiology*; D006131:Growth Inhibitors / Q000096:biosynthesis / Q000502:physiology*; D006801:Humans; D007372:Interferons / Q000502:physiology; D055646:Killer Factors, Yeast; D007951:Leukemia, Myeloid / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism; D008222:Lymphokines / Q000096:biosynthesis / Q000502:physiology*; D008233:Lymphotoxin-alpha / Q000502:physiology*; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000378:metabolism; D011506:Proteins / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha
D006023:Glycoproteins; D006131:Growth Inhibitors; D055646:Killer Factors, Yeast; D008222:Lymphokines; D008233:Lymphotoxin-alpha; D011506:Proteins; D014409:Tumor Necrosis Factor-alpha; C044162:leukoregulin; D007372:Interferons